Chapter: 1 INTRODUCTION

1.1 Key benefits
1.2 Key market segments
1.3 Key audiences
1.4 Research methodology

1.4.1 Primary research
1.4.2 Secondary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2020

2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Government regulations

3.3.1 US-FDA perspective
3.3.2 EU EMEA perspective
3.3.3 Japan MHW perspective

3.4 Nanotechnology in excipient
3.5 Emerging role of excipients in the pharmaceutical industry
3.6 Porters five force analysis

3.6.1 Limited suppliers increase bargaining power
3.6.2 Lesser bargaining power of buyers due to intense competition
3.6.3 Lesser hazard from substitutes due to high fixed cost
3.6.4 Lesser threats from new entrants due to high capital investment
3.6.5 Superficial competition due to lesser global players

3.7 Value chain analysis
3.8 Patent analysis
3.9 Clinical trials

3.9.1 A study of insulin lispro with biochaperone excipients in healthy participants
3.9.2 Understanding typhoid disease after vaccination
3.9.3 Clinical trial no. 2 effect on acetaminophen metabolism by liquid formulations
3.9.4 Class 3 biowaivers
3.9.5 Phase 1 Norwalk vaccine study

3.10 Market dynamics

3.10.1 Drivers

3.10.1.1 Positive momentum of pharmaceutical industries
3.10.1.2 Impact of new excipients on the pharmaceutical industry
3.10.1.3 Diversified geographic market that reduces earnings

3.10.2 Restraints

3.10.2.1 Supply chain issues
3.10.2.2 SegregatedPHARMACEUTICAL EXCIPIENTS market that reduces earnings
3.10.2.3 Higher production cost
3.10.2.4 Stringent government regulations
3.10.2.5 Declining R&D investment

3.10.3 Opportunities

3.10.3.1 Opportunities in developing economies
3.10.3.2 New product development

Chapter 4 PHARMACEUTICAL EXCIPIENTS MARKET BY TYPE, 2014-2020

4.1 Overview

4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast

4.2 Inorganic Chemicals

4.2.1 Market size and forecast
4.2.2 Calcium Phosphates

4.2.2.1 Market size and forecast

4.2.3 Calcium Carbonate

4.2.3.1 Market size and forecast

4.2.4 Calcium Sulfate

4.2.4.1 Market size and forecast

4.2.5 Halites

4.2.5.1 Market size and forecast

4.2.6 Metallic Oxides

4.2.6.1 Market size and forecast

4.2.7 Others

4.2.7.1 Market size and forecast

4.3 Organic chemicals

4.3.1 Market size and forecast
4.3.2 Carbohydrates

4.3.2.1 Market size and foreast
4.3.2.2 Sugars

4.3.2.2.1 MARKET SIZE AND FORECAST

4.3.2.3 Starch

4.3.2.3.1 MARKET SIZE AND FORECAST

4.3.2.4 Cellulose

4.3.2.4.1 MARKET SIZE AND FORECAST

4.3.3 Petrochemicals

4.3.3.1 Market size and forecast
4.3.3.2 Glycols (Alcohol)

4.3.3.2.1 MARKET SIZE AND FORECAST

4.3.3.3 Povidones Polymers

4.3.3.3.1 MARKET SIZE AND FORECAST

4.3.3.4 Mineral Hydrocarbons

4.3.3.4.1 MARKET SIZE AND FORECAST

4.3.3.5 Oleochemicals

4.3.3.5.1 MARKET SIZE AND FORECAST

4.3.3.6 Gelatin (Proteins)

4.3.3.6.1 MARKET SIZE AND FORECAST

Chapter 5 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2014-2020

5.1 Overview

5.1.1 Key market trends
5.1.2 Key growth factors and opportunities
5.1.3 Market size and forecast

5.2 Fillers & Diluents

5.2.1 Market size and forecast

5.3 Suspension & viscosity agents

5.3.1 Market size and forecast

5.4 Binders

5.4.1 Market size and forecast

5.5 Coatings

5.5.1 Market size and forecast

5.6 Flavoring agents

5.6.1 Market size and forecast

5.7 Disintegrants

5.7.1 Market size and forecast

5.8 Colorants

5.8.1 Market size and forecast

5.9 Others

5.9.1 Lubricants & Glidants

5.9.1.1 Role of lubricants

5.9.2 Preservatives
5.9.3 Market size and forecast

Chapter 6 PHARMACEUTICAL EXCIPIENTS MARKET BY GEOGRAPHY, 2014-2020

6.1 Overview
6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

Chapter 7 COMPANY PROFILES

7.1 Ashland Inc.

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Key strategies of Ashland Inc.

7.1.4.1 Primary Strategies: Product Launch
7.1.4.2 Secondary Strategies: Agreement

7.1.5 SWOT analysis of Ashland Inc.

7.2 Associated British Food Plc

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Business performance
7.2.4 Key strategies of Associated British Food Plc

7.2.4.1 Primary Strategies: Product Launch
7.2.4.2 Secondary Strategies: Alliance

7.2.5 SWOT analysis of Associated British Food Plc

7.3 AkzoNobel

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Key strategies of AkzoNobel

7.3.3.1 Primary Strategies: Expansion
7.3.3.2 Secondary Strategies: acquisition

7.3.4 SWOT analysis of AkzoNobel

7.4 Evonik

7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Business performance
7.4.4 Key strategies of Evonik

7.4.4.1 Primary Strategies: Investments
7.4.4.2 Secondary Strategies: Expansion

7.4.5 SWOT analysis of Evonik

7.5 J.M. Huber Corporation

7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Key strategies of J.M. Huber Corporation

7.5.3.1 Primary Strategies: expansion

7.5.4 SWOT analysis of J.M. Huber Corporation

7.6 Archer Daniels Midland

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Key strategies of Archer Daniels Midland

7.6.3.1 Primary Strategies: Product launch
7.6.3.2 Secondary Strategies: collaborations

7.6.4 SWOT analysis of Archer Daniels Midland

7.7 BASF

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Key strategies of BASF

7.7.3.1 Primary Strategies: Innovation
7.7.3.2 Secondary Strategies: acquisition

7.7.4 SWOT analysis of BASF

7.8 Dow Chemical Corporation

7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Business performance
7.8.4 Key strategies of Dow Chemical Corporation

7.8.4.1 Primary Strategies: Collboration
7.8.4.2 Secondary Strategies: new product launches

7.8.5 SWOT analysis of Dow Chemical Corporation

7.9 Merck Millipore

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Business performance
7.9.4 Key strategies of Merck Millipore

7.9.4.1 Primary Strategies: Product Launch

7.9.5 SWOT analysis of Merck Millipore

7.10 Croda International plc

7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Business performance
7.10.4 Key strategies of Croda International plc.

7.10.4.1 Primary Strategies: approval and expansion

7.10.5 SWOT analysis of Croda International plc.